CORONA REMEDIES LIMITED (CORONA)

NSE: ₹1,701.30
BSE: ₹1,701.95
Back to Home
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 361.13 342.42 353.09
YOY Revenue Growth % - - -
Other Income 2.27 2.24 4.11
Total Income 363.40 344.66 357.20
Total Expenses + 293.79 270.37 302.74
Cost of Materials Consumed 25.90 24.82 27.73
Employee Benefit Expense 103.00 95.94 106.63
Other Expenses 111.01 103.05 118.20
Operating Profit 67.34 72.05 50.35
OPM % 18.6% 21% 14.3%
Profit Before Tax + 69.61 55.19 54.46
Tax Expense 17.46 13.94 9.41
Tax % 25.1% 25.3% 17.3%
Profit After Tax 52.15 41.25 45.05
EPS (Basic) 8.53 6.74 7.37

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Standalone.